Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

Kenvue's has fired CEO Thibaut Mongon, who has also stepped down from the board, the consumer health company said on Monday, ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive ...

Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue , sources familiar with the matter said on Friday, as some investors are pushing for strategic changes at ...

Kenvue plans to cut 69 jobs at its Summit HQ as part of global restructuring after splitting from Johnson & Johnson.

The report shares how Kenvue has helped advance the well-being of both people and planet in 2024, with progress noted across three pillars: Healthy People, Healthy Planet, and Healthy Practice.

On June 26, Kenvue, which is more commonly known for some of its brands like Neutrogena, Listerine, Aveeno, and Tylenol, released its second annual Healthy Lives Mission Report.

Investors in Kenvue Inc (Symbol: KVUE) saw new options begin trading today, for the December 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay ...